How will the newly ACIP operate? We’ll soon find out.
A once-obscure federal committee is now at the center of a political firestorm. This week the Advisory Committee on Immunization Practices (ACIP), which has helped guide national vaccine policy since the 1960s, will hold its first meeting since all 17 of its members were abruptly dismissed by Health and Human Services Secretary Robert F. Kennedy Jr. The move—and the appointment of new members known for controversial views—has raised alarm among public health professionals and has brought national attention to a group that few Americans had previously heard of.
What is ACIP, why does its work matter and how does it impact families and communities across the country? Here’s a quick overview.
What is the Advisory Committee on Immunization Practices (ACIP)?
ACIP is a scientific advisory panel that helps the Centers for Disease Control and Prevention (CDC) decide who should get which vaccines and when, and its recommendations also shape decisions about what insurers and Medicaid programs will cover. The committee makes recommendations about vaccines that have been approved or authorized for use by the Food and Drug Administration. These recommendations typically inform final, official recommendations that are made by the CDC director, though the director is not required to adopt the recommendations.
What is the purpose of ACIP?
ACIP’s mission is to guide how vaccines are used in the United States, based on scientific evidence, public health need and practical implementation. At the time the Office of the Surgeon General created ACIP in 1964, several new vaccines for diseases such as measles and polio had been developed and made available to the public for the first time. The minutes of the first ACIP meeting explained its purpose as follows: “The Committee shall concern itself with immunization schedules, dosages and routes of administration and indications and contraindications for the use of these agents…The Committee shall also provide advice as to the relative priority of various population groups to whom the agents should be made available and shall advise regarding the relative merits and methods for conducting mass immunization programs.”
Why does the work of ACIP matter?
Almost all insurers cover vaccines recommended by ACIP and the CDC, typically with no cost to patients. So ACIP’s recommendations directly affect whether vaccines are accessible and affordable, especially for children, low-income families and underserved communities.
How does ACIP operate and how does it ensure transparency?
ACIP operates under strict transparency rules. Its meetings, typically held three times a year, are public, votes are recorded and conflicts of interest must be disclosed in advance. If conflicts do arise, those members must recuse themselves from related votes. The public has an opportunity to weigh in both prior to and during the meetings.
Who serves on ACIP, and how are its members appointed?
ACIP is typically composed of vaccine experts appointed by the Secretary of Health and Human Services, such as scientists, physicians and epidemiologists. By law, they cannot be federal government employees or be employed by vaccine manufacturers. Instead, they have a “special government employee” designation to avoid conflicts of interest, especially financial ones. A consumer representative serves on the committee, as do non-voting representatives from organizations that can help inform their deliberations, such as the American Academy of Pediatrics (AAP). Prospective committee members typically undergo an extensive vetting process; once named, they are appointed to serve four-year terms.
Why did Secretary Kennedy fire the 17 current ACIP members? What do we know about their replacements?
Secretary Kennedy said he dismissed all 17 ACIP members because the panel was “plagued with persistent conflicts of interest” and had become “a rubber stamp for any vaccine.” Major medical groups strongly rejected that claim. The American Academy of Pediatrics called their removal an “unprecedented” and said it reflected ”an escalating effort…to silence independent medical expertise and stoke distrust in lifesaving vaccines.”
While Secretary Kennedy praised the new appointees as “highly credentialed,” several of them have publicly questioned the safety and effectiveness of vaccines—positions that conflict with decades of scientific consensus. AAP said the appointments “represent a radical departure from ACIP’s core mission.”
On June 22, it was reported that several groups—including AAP, the American Academy of Family Physicians, the American College of Physicians, the American Pharmacists Association, the National Foundation for Infectious Diseases and some health insurers—are considering creating an alternate vaccine panel.
What’s next for ACIP?
ACIP’s next meeting, on June 25-27, will be the first test of how the newly reconstituted panel will operate, and how much of their work adheres to scientific integrity. With some pediatric groups and public health organizations considering alternate paths, national vaccine policy may be headed into uncharted territory.
